SCHEMBL19082151

SCHEMBL19082151

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)sc4ccc6sc7cc8ccccc8cc7c6c45)c4ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.41
ESR2 Q92731 8/20 0.41
F9 P00740 2/20 0.34
LIMK1 P53667 1/20 0.34
MCL1 Q07820 1/20 0.33
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
PTPN1 P18031 2/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CHEK1 O14757 1/20 0.31
WEE1 P30291 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944194 0.88 MAPT (0.41) F9LIMK1MCL1PTPN1ALDH1A1
SCHEMBL17247101 0.88 ESR1 (0.45) ESR1ESR2F9LIMK1MCL1
SCHEMBL17944806 0.87 CYP1A1 (0.38) ESR1ESR2F9LIMK1MCL1
SCHEMBL23502095 0.87 LIMK1 (0.36) ESR1ESR2F9LIMK1MCL1
SCHEMBL17945002 0.87 MAPT (0.42) F9LIMK1MCL1PTPN1ALDH1A1
SCHEMBL17246875 0.87 ESR1 (0.46) ESR1ESR2LIMK1MCL1PIK3CA
SCHEMBL13507134 0.86 ESR1 (0.39) ESR1ESR2F9LIMK1MCL1
SCHEMBL19081825 0.86 ESR1 (0.35) ESR1ESR2LIMK1MCL1ALOX5
SCHEMBL17944622 0.86 F9 (0.40) ESR1ESR2F9LIMK1MCL1
SCHEMBL13507025 0.86 ESR1 (0.38) ESR1ESR2F9ALOX5CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885F9 1203/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885F9 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.